Search Results - M V Cherkasova

Refine Results
  1. 1
    Dynamics of the level of calprotectin in patients with rheumatoid arthritis during rituximab biosimilar (Acellbia “Biocad”) therapy

    Dynamics of the level of calprotectin in patients with rheumatoid arthritis during rituximab biosimilar (Acellbia “Biocad”) therapy by A. S. Avdeeva, M. V. Cherkasova, E. L. Nasonov

    Published 2021-09-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    CLINICAL ASSOCIATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS TYPE 2 RECEPTOR IN SYSTEMIC SCLEROSIS

    CLINICAL ASSOCIATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS TYPE 2 RECEPTOR IN SYSTEMIC SCLEROSIS by R. T. Alekperov, L. P. Ananyeva, M. V. Cherkasova

    Published 2018-11-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Different clinical relevance of anti-citrullinated proteins antibodies in RA patients

    Different clinical relevance of anti-citrullinated proteins antibodies in RA patients by A. S. Avdeeva, M. V. Cherkasova, E. L. Nasonov

    Published 2022-05-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Perception of Russian Politics in Galicia in Diaries and Memoirs of World War I Participants

    Perception of Russian Politics in Galicia in Diaries and Memoirs of World War I Participants by Yu. A. Zherdeva, E. I. Sumburova, M. V. Cherkasova

    Published 2021-08-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Serum amyloid A as a marker of ankylosing spondylitis activity

    Serum amyloid A as a marker of ankylosing spondylitis activity by K. V. Sakharova, M. V. Cherkasova, Sh. F. Erdes

    Published 2021-12-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: and is that so great?

    The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: and is that so great? by E. V. Sokol, M. V. Cherkasova, A. V. Torgashina

    Published 2019-03-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Citrullinated histone H3 in systemic lupus erythematosus and antiphospholipid syndrome (preliminary results)

    Citrullinated histone H3 in systemic lupus erythematosus and antiphospholipid syndrome (preliminary results) by K. S. Nurbaeva, T. M. Reshetnyak, M. V. Cherkasova, A. M. Lila

    Published 2023-08-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use

    Vaccination of pneumococcal infection in patients with systemic lupus erythe matosus and antiphospholipid syndrome: experience of 6 years of use by G. M. Tarasova, B. S. Belov, T. M. Reshetnyak, M. V. Cherkasova

    Published 2023-06-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Current methods for laboratory diagnosis of rheumatoid arthritis

    Current methods for laboratory diagnosis of rheumatoid arthritis by A A Novikov, E N Aleksandrova, M V Cherkasova, E L Nasonov, A A Novikov, E N Aleksandrova, M V Cherkasova, E L Nasonov

    Published 2010-02-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Anti-Mullerian hormone in systemic lupus erythematosus

    Anti-Mullerian hormone in systemic lupus erythematosus by Z. S. Alekberova, O. N. Egorova, R. G. Goloeva, M. V. Cherkasova

    Published 2021-02-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Dynamics of lymphocyte subpopulations, CD4+CD25+CD127- T regulatory cells in patients with rheumatoid arthritis during therapy with the rituximab biosimilar Acellbia

    Dynamics of lymphocyte subpopulations, CD4+CD25+CD127- T regulatory cells in patients with rheumatoid arthritis during therapy with the rituximab biosimilar Acellbia by A. S. Avdeeva, Yu. P. Rubtsov, M. V. Cherkasova, E. L. Nasonov

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Clinical features of patients with ankylosing spondylitis with inefficacy of two or more biological disease modifying antirheumatic drugs

    Clinical features of patients with ankylosing spondylitis with inefficacy of two or more biological disease modifying antirheumatic drugs by Sh. F. Erdes, K. V. Sakharova, T. V. Dubinina, M. V. Cherkasova

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)

    Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data) by F. A. Cheldieva, T. M. Reshetnyak, M. V. Cherkasova, A. M. Lila

    Published 2021-10-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Clinical significance of antibodies to the phosphatidylserine/prothrombin complex

    Clinical significance of antibodies to the phosphatidylserine/prothrombin complex by T. M. Reshetnyak, F. A. Cheldieva, M. V. Cherkasova, A. M. Lila

    Published 2022-05-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor

    Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhi... by E. V. Gerasimova, T. V. Popkova, A. V. Martynova, M. V. Cherkasova, D. S. Novikova

    Published 2019-11-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method

    Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method by T. M. Reshetnyak, M. V. Cherkasova, F. A. Cheldieva, K. S. Nurbaeva, A. M. Lila

    Published 2025-04-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Clinical significance of leptin in systemic lupus erythematosus

    Clinical significance of leptin in systemic lupus erythematosus by L. V. Kondratyeva, T. A. Panafidina, T. V. Popkova, Yu. N. Gorbunova, M. V. Cherkasova

    Published 2021-12-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Changes of cytokine profile measures during the treatment of rheumatoid arthritis with rituximab biosimilar (Acellbia, BIOCAD) and the original drug (MabThera, F. Hoffmann-La Roche Ltd., Switzerland)

    Changes of cytokine profile measures during the treatment of rheumatoid arthritis with rituximab biosimilar (Acellbia, BIOCAD) and the original drug (MabThera, F. Hoffmann-La Roche... by A. S. Avdeeva, A. S. Artyukhov, E. B. Dashinimaeva, M. V. Cherkasova, E. L. Nasonov

    Published 2019-03-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Serum calprotectin in Behcet's disease

    Serum calprotectin in Behcet's disease by K. S. Nurbaeva, M. V. Cherkasova, R. G. Goloeva, A. M. Lila, T. M. Reshetnyak

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Insulin resistance and type 2 diabetes mellitus risk factors in systemic lupus erythematosus

    Insulin resistance and type 2 diabetes mellitus risk factors in systemic lupus erythematosus by L. V. Kondratyeva, T. V. Popkova, M. V. Cherkasova, A. M. Lila, E. L. Nasonov

    Published 2021-09-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: